Georges Fournier
Research Subjects
Georges Fournier has a total of 190 co-authors. Here are the top co-authors by number of shared publications:
- Antoine Valeri
Urology Department, Brest University Hospital, CHU Brest, Brest, France; Faculté de Médecine et des Sciences de la Santé, Université de Bretagne Occidentale, Brest, France; LaTIM, INSERM, UMR 1101, Université de Bretagne Occidentale, Brest, France; Centre recherche pathologies prostatiques , Paris, France
20 shared publications - Olivier Cussenot
Universitätsklinik für Urologie, Medical University Vienna, Vienna, Austria; Centre de Recherche sur les Pathologies Prostatiques, Paris, France
16 shared publications P Mangin
11 shared publicationsC. Deruelle
9 shared publicationsV. Joulin
9 shared publicationsL. Doucet
8 shared publications
Latest Publications
- Open Access
- 6 January 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (1) , 284
Open vs. Robot-Assisted Artificial Urinary Sphincter Implantation in Women with Stress Urinary Incontinence: A Multicenter Comparative Study
Background: The artificial urinary sphincter has been an effective treatment for stress urinary incontinence caused by intrinsic sphincter deficiency in women. However, the use of this device has been limited by the technical difficulties and risks associated with the open implantation procedure. Preliminary studies using robotic techniques have shown promising results, but only one small study has compared robotic to open procedures. This study aims to compare the outcomes of robotic and open artificial urinary sphincter implantation in women with stress urinary incontinence due to intrinsic sphincter deficiency in a large multicenter cohort. Methods: Data were collected retrospectively from female patients who underwent open or robot-assisted artificial urinary sphincter implantation from 2006 to 2020 at 12 urology departments. The primary outcome was the rate of complications within 30 days after surgery, graded using the Clavien-Dindo Classification. Perioperative and functional outcomes were compared between the two groups. Results: A total of 135 patients were included, with 71 in the robotic group and 64 in the open group. The open group had a higher rate of intraoperative complications (27.4% vs. 12.7%; p = 0.03) and postoperative complications (46.8% vs. 15.5%; p < 0.0001). More patients in the robotic group achieved full continence (83.3% vs. 62.3%; p = 0.01). The open group had higher explantation (27.4% vs. 1.4%; p < 0.0001) and revision rates (17.5% vs. 5.6%; p = 0.02). The estimated 1-year explantation-free survival rate was higher in the robotic group. (98.6% vs. 78.3%; p = 0.001). Conclusions: Robot-assisted implantation may reduce perioperative morbidity and improve functional outcomes compared to open implantation in women with stress urinary incontinence.
- 6 January 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (1) , 284
Open AccessOpen vs. Robot-Assisted Artificial Urinary Sphincter Implantation in Women with Stress Urinary Incontinence: A Multicenter Comparative Study
Background: The artificial urinary sphincter has been an effective treatment for stress urinary incontinence caused by intrinsic sphincter deficiency in women. However, the use of this device has been limited by the technical difficulties and risks associated with the open implantation procedure. Preliminary studies using robotic techniques have shown promising results, but only one small study has compared robotic to open procedures. This study aims to compare the outcomes of robotic and open artificial urinary sphincter implantation in women with stress urinary incontinence due to intrinsic sphincter deficiency in a large multicenter cohort. Methods: Data were collected retrospectively from female patients who underwent open or robot-assisted artificial urinary sphincter implantation from 2006 to 2020 at 12 urology departments. The primary outcome was the rate of complications within 30 days after surgery, graded using the Clavien-Dindo Classification. Perioperative and functional outcomes were compared between the two groups. Results: A total of 135 patients were included, with 71 in the robotic group and 64 in the open group. The open group had a higher rate of intraoperative complications (27.4% vs. 12.7%; p = 0.03) and postoperative complications (46.8% vs. 15.5%; p < 0.0001). More patients in the robotic group achieved full continence (83.3% vs. 62.3%; p = 0.01). The open group had higher explantation (27.4% vs. 1.4%; p < 0.0001) and revision rates (17.5% vs. 5.6%; p = 0.02). The estimated 1-year explantation-free survival rate was higher in the robotic group. (98.6% vs. 78.3%; p = 0.001). Conclusions: Robot-assisted implantation may reduce perioperative morbidity and improve functional outcomes compared to open implantation in women with stress urinary incontinence.
- Open Access
- 14 December 2023
- Published by MDPI AG in Biomedicines
- Vol. 11 (12) , 3309
Inter-Rater Variability of Prostate Lesion Segmentation on Multiparametric Prostate MRI
Introduction: External radiotherapy is a major treatment for localized prostate cancer (PCa). Dose escalation to the whole prostate gland increases biochemical relapse-free survival but also acute and late toxicities. Dose escalation to the dominant index lesion (DIL) only is of growing interest. It requires a robust delineation of the DIL. In this context, we aimed to evaluate the inter-observer variability of DIL delineation. Material and Methods: Two junior radiologists and a senior radiation oncologist delineated DILs on 64 mpMRIs of patients with histologically confirmed PCa. For each mpMRI and each reader, eight individual DIL segmentations were delineated. These delineations were blindly performed from one another and resulted from the individual analysis of the T2, apparent diffusion coefficient (ADC), b2000, and dynamic contrast enhanced (DCE) sequences, as well as the analysis of combined sequences (T2ADC, T2ADCb2000, T2ADCDCE, and T2ADCb2000DCE). Delineation variability was assessed using the DICE coefficient, Jaccard index, Hausdorff distance measure, and mean distance to agreement. Results: T2, ADC, T2ADC, b2000, T2 + ADC + b2000, T2 + ADC + DCE, and T2 + ADC + b2000 + DCE sequences obtained DICE coefficients of 0.51, 0.50, 0.54, 0.52, 0.54, 0.55, 0.53, respectively, which are significantly higher than the perfusion sequence alone (0.35, p < 0.001). The analysis of other similarity metrics lead to similar results. The tumor volume and PI-RADS classification were positively correlated with the DICE scores. Conclusion: Our study showed that the contours of prostatic lesions were more reproducible on certain sequences but confirmed the great variability of prostatic contours with a maximum DICE coefficient calculated at 0.55 (joint analysis of T2, ADC, and perfusion sequences).
- 14 December 2023
- Published by MDPI AG in Biomedicines
- Vol. 11 (12) , 3309
Open AccessInter-Rater Variability of Prostate Lesion Segmentation on Multiparametric Prostate MRI
Introduction: External radiotherapy is a major treatment for localized prostate cancer (PCa). Dose escalation to the whole prostate gland increases biochemical relapse-free survival but also acute and late toxicities. Dose escalation to the dominant index lesion (DIL) only is of growing interest. It requires a robust delineation of the DIL. In this context, we aimed to evaluate the inter-observer variability of DIL delineation. Material and Methods: Two junior radiologists and a senior radiation oncologist delineated DILs on 64 mpMRIs of patients with histologically confirmed PCa. For each mpMRI and each reader, eight individual DIL segmentations were delineated. These delineations were blindly performed from one another and resulted from the individual analysis of the T2, apparent diffusion coefficient (ADC), b2000, and dynamic contrast enhanced (DCE) sequences, as well as the analysis of combined sequences (T2ADC, T2ADCb2000, T2ADCDCE, and T2ADCb2000DCE). Delineation variability was assessed using the DICE coefficient, Jaccard index, Hausdorff distance measure, and mean distance to agreement. Results: T2, ADC, T2ADC, b2000, T2 + ADC + b2000, T2 + ADC + DCE, and T2 + ADC + b2000 + DCE sequences obtained DICE coefficients of 0.51, 0.50, 0.54, 0.52, 0.54, 0.55, 0.53, respectively, which are significantly higher than the perfusion sequence alone (0.35, p < 0.001). The analysis of other similarity metrics lead to similar results. The tumor volume and PI-RADS classification were positively correlated with the DICE scores. Conclusion: Our study showed that the contours of prostatic lesions were more reproducible on certain sequences but confirmed the great variability of prostatic contours with a maximum DICE coefficient calculated at 0.55 (joint analysis of T2, ADC, and perfusion sequences).
- Open Access
Development of a Radiomic-Based Model Predicting Lymph Node Involvement in Prostate Cancer Patients
Significant advances in lymph node involvement (LNI) risk modeling in prostate cancer (PCa) have been achieved with the addition of visual interpretation of magnetic resonance imaging (MRI) data, but it is likely that quantitative analysis could further improve prediction models. In this study, we aimed to develop and internally validate a novel LNI risk prediction model based on radiomic features extracted from preoperative multimodal MRI. All patients who underwent a preoperative MRI and radical prostatectomy with extensive lymph node dissection were retrospectively included in a single institution. Patients were randomly divided into the training (60%) and testing (40%) sets. Radiomic features were extracted from the index tumor volumes, delineated on the apparent diffusion coefficient corrected map and the T2 sequences. A ComBat harmonization method was applied to account for inter-site heterogeneity. A prediction model was trained using a neural network approach (Multilayer Perceptron Network, SPSS v24.0©) combining clinical, radiomic and all features. It was then evaluated on the testing set and compared to the current available models using the Receiver Operative Characteristics and the C-Index. Two hundred and eighty patients were included, with a median age of 65.2 y (45.3–79.6), a mean PSA level of 9.5 ng/mL (1.04–63.0) and 79.6% of ISUP ≥ 2 tumors. LNI occurred in 51 patients (18.2%), with a median number of extracted nodes of 15 (10–19). In the testing set, with their respective cutoffs applied, the Partin, Roach, Yale, MSKCC, Briganti 2012 and 2017 models resulted in a C-Index of 0.71, 0.66, 0.55, 0.67, 0.65 and 0.73, respectively, while our proposed combined model resulted in a C-Index of 0.89 in the testing set. Radiomic features extracted from the preoperative MRI scans and combined with clinical features through a neural network seem to provide added predictive performance compared to state of the art models regarding LNI risk prediction in PCa.
Open AccessDevelopment of a Radiomic-Based Model Predicting Lymph Node Involvement in Prostate Cancer Patients
Significant advances in lymph node involvement (LNI) risk modeling in prostate cancer (PCa) have been achieved with the addition of visual interpretation of magnetic resonance imaging (MRI) data, but it is likely that quantitative analysis could further improve prediction models. In this study, we aimed to develop and internally validate a novel LNI risk prediction model based on radiomic features extracted from preoperative multimodal MRI. All patients who underwent a preoperative MRI and radical prostatectomy with extensive lymph node dissection were retrospectively included in a single institution. Patients were randomly divided into the training (60%) and testing (40%) sets. Radiomic features were extracted from the index tumor volumes, delineated on the apparent diffusion coefficient corrected map and the T2 sequences. A ComBat harmonization method was applied to account for inter-site heterogeneity. A prediction model was trained using a neural network approach (Multilayer Perceptron Network, SPSS v24.0©) combining clinical, radiomic and all features. It was then evaluated on the testing set and compared to the current available models using the Receiver Operative Characteristics and the C-Index. Two hundred and eighty patients were included, with a median age of 65.2 y (45.3–79.6), a mean PSA level of 9.5 ng/mL (1.04–63.0) and 79.6% of ISUP ≥ 2 tumors. LNI occurred in 51 patients (18.2%), with a median number of extracted nodes of 15 (10–19). In the testing set, with their respective cutoffs applied, the Partin, Roach, Yale, MSKCC, Briganti 2012 and 2017 models resulted in a C-Index of 0.71, 0.66, 0.55, 0.67, 0.65 and 0.73, respectively, while our proposed combined model resulted in a C-Index of 0.89 in the testing set. Radiomic features extracted from the preoperative MRI scans and combined with clinical features through a neural network seem to provide added predictive performance compared to state of the art models regarding LNI risk prediction in PCa.
- Open Access
- 27 December 2018
- Published by Springer Nature in Trials
- Vol. 19 (1) , 1-8
Stopping or maintaining oral anticoagulation in patients undergoing photoselective vaporization of the prostate (SOAP) surgery for benign prostate obstruction: study protocol for a multicentre randomized controlled trial
Lower urinary tract symptoms related to benign prostatic obstruction (BPO) are frequent in men aged > 50 years. Based on the use of innovative medical devices, a number of transurethral ablative techniques have recently been developed for the surgical treatment of BPO. In recent years, GreenLight photoselective vaporization of the prostate (PVP) has been considered as a non-inferior alternative to transurethral resection of the prostate. The GreenLight PVP is usually considered as an interesting surgical option for patients treated via oral anticoagulants (OACs) with regard to its haemostatic properties. The aim of this study was to assess the impact of maintaining OAC treatment in patients undergoing PVP. This study is a multicentre, open-label, randomized controlled trial (RCT) designed to show the non-inferiority of PVP surgery in patients with BPO treated with OACs. This study is designed to enrol 386 OAC-treated patients (treated with vitamin K antagonists and direct oral anticoagulants) who are undergoing PVP for BPO. Patients will be randomized (1:1) to either maintain or stop OAC treatment during the perioperative course. The intervention group will maintain OAC treatment until the day before surgery and resume OAC treatment the day after surgery, whereas the control group will stop OAC treatment (with or without low-molecular-weight heparin bridging therapy) according to the anaesthesia guidelines. The primary outcome of interest to be assessed is the 30-day complications rate according to the Clavien-Dindo classification. The secondary endpoint will examine the 30-day rate of haemorrhagic and thrombotic events. This study will provide 80% power to show non-inferiority, defined as not worse than a 10% (non-inferiority margin) inferior change in the proportion of patients with good outcomes (Clavien-Dindo score < 2), using two-tailed 95% confidence intervals. This first multicentre RCT in the field is underway to evaluate the safety and efficacy of PVP in patients with ongoing OAC therapy. The study results could influence the perioperative management of OACs in BPO surgery with a high level of evidence. ClinicalTrials.gov, NCT03297281 . Registered on 29 September 2017.
- 27 December 2018
- Published by Springer Nature in Trials
- Vol. 19 (1) , 1-8
Open AccessStopping or maintaining oral anticoagulation in patients undergoing photoselective vaporization of the prostate (SOAP) surgery for benign prostate obstruction: study protocol for a multicentre randomized controlled trial
Lower urinary tract symptoms related to benign prostatic obstruction (BPO) are frequent in men aged > 50 years. Based on the use of innovative medical devices, a number of transurethral ablative techniques have recently been developed for the surgical treatment of BPO. In recent years, GreenLight photoselective vaporization of the prostate (PVP) has been considered as a non-inferior alternative to transurethral resection of the prostate. The GreenLight PVP is usually considered as an interesting surgical option for patients treated via oral anticoagulants (OACs) with regard to its haemostatic properties. The aim of this study was to assess the impact of maintaining OAC treatment in patients undergoing PVP. This study is a multicentre, open-label, randomized controlled trial (RCT) designed to show the non-inferiority of PVP surgery in patients with BPO treated with OACs. This study is designed to enrol 386 OAC-treated patients (treated with vitamin K antagonists and direct oral anticoagulants) who are undergoing PVP for BPO. Patients will be randomized (1:1) to either maintain or stop OAC treatment during the perioperative course. The intervention group will maintain OAC treatment until the day before surgery and resume OAC treatment the day after surgery, whereas the control group will stop OAC treatment (with or without low-molecular-weight heparin bridging therapy) according to the anaesthesia guidelines. The primary outcome of interest to be assessed is the 30-day complications rate according to the Clavien-Dindo classification. The secondary endpoint will examine the 30-day rate of haemorrhagic and thrombotic events. This study will provide 80% power to show non-inferiority, defined as not worse than a 10% (non-inferiority margin) inferior change in the proportion of patients with good outcomes (Clavien-Dindo score < 2), using two-tailed 95% confidence intervals. This first multicentre RCT in the field is underway to evaluate the safety and efficacy of PVP in patients with ongoing OAC therapy. The study results could influence the perioperative management of OACs in BPO surgery with a high level of evidence. ClinicalTrials.gov, NCT03297281 . Registered on 29 September 2017.
- 1 March 2017
- Published by Elsevier in European Urology Supplements
- Vol. 16 (3) , e416-e417
Prostate cancer screening in high risk families: Should PSA testing be performed yearly in first degree relatives with baseline PSA ≤ 1ng/ml?
- 1 March 2017
- Published by Elsevier in European Urology Supplements
- Vol. 16 (3) , e416-e417
Prostate cancer screening in high risk families: Should PSA testing be performed yearly in first degree relatives with baseline PSA ≤ 1ng/ml?
- 1 March 2017
- Published by Elsevier in European Urology Supplements
- Vol. 16 (3) , e1496-e1500
Robot-assisted artificial urinary sphincter implantation in female patients: A multicenter study
- 1 March 2017
- Published by Elsevier in European Urology Supplements
- Vol. 16 (3) , e1496-e1500
Robot-assisted artificial urinary sphincter implantation in female patients: A multicenter study
- 1 May 2016
- Published by Walter de Gruyter GmbH in Oncologie
- Vol. 18 (5) , 336-338
Impact de l’assistance robotique sur la pratique chirurgicale
Résumé L’assistance robotique par le robot Da Vinci® a profondément modifié la pratique chirurgicale du fait des caractéristiques techniques et également par le coût élevé de l’instrument. Le changement principal est de ne plus être au contact direct du patient. Cela a conduit à déléguer à l’assistant des fonctions visant à assurer la sécurité. L’autre changement est la perte du toucher du fait de l’absence de retour de force des instruments. La vision en trois dimensions du champ opératoire constitue une très grande amélioration, plus proche de la vision naturelle, et la mobilité articulée de l’extrémité des instruments procure une aisance supérieure à celle de la laparoscopie manuelle... Ces améliorations ont amplifié les possibilités chirurgicales de la coelioscopie. L’existence d’un simulateur permet de réduire la courbe d’apprentissage du nouveau chirurgien. D’autres changements sont apparus du fait du coût élevé, créant des établissements de santé avec et sans robots, avec des conséquences inévitables en termes de recrutement des patients et d’activité chirurgicale.
- 1 May 2016
- Published by Walter de Gruyter GmbH in Oncologie
- Vol. 18 (5) , 336-338
Impact de l’assistance robotique sur la pratique chirurgicale
Résumé L’assistance robotique par le robot Da Vinci® a profondément modifié la pratique chirurgicale du fait des caractéristiques techniques et également par le coût élevé de l’instrument. Le changement principal est de ne plus être au contact direct du patient. Cela a conduit à déléguer à l’assistant des fonctions visant à assurer la sécurité. L’autre changement est la perte du toucher du fait de l’absence de retour de force des instruments. La vision en trois dimensions du champ opératoire constitue une très grande amélioration, plus proche de la vision naturelle, et la mobilité articulée de l’extrémité des instruments procure une aisance supérieure à celle de la laparoscopie manuelle... Ces améliorations ont amplifié les possibilités chirurgicales de la coelioscopie. L’existence d’un simulateur permet de réduire la courbe d’apprentissage du nouveau chirurgien. D’autres changements sont apparus du fait du coût élevé, créant des établissements de santé avec et sans robots, avec des conséquences inévitables en termes de recrutement des patients et d’activité chirurgicale.
- 1 May 2016
- Published by Walter de Gruyter GmbH in Oncologie
- Vol. 18 (5) , 298-304
Chirurgie robot-assistée en uro-oncologie
Résumé La prostatectomie totale et la néphrectomie partielle robot-assistées sont les interventions les plus pratiquées en onco-urologie. En dix ans, la robotique s’est imposée pour la prostatectomie dans les centres équipés, du fait de l’amélioration technique apportée à la réalisation de cette intervention. Les résultats carcinologiques et fonctionnels sont comparables ou supérieurs à ceux de la prostatectomie laparoscopique ou par voie ouverte. L’assistance robotique est particulièrement utile en cas de patient obèse et de nécessité de dissection précise (conservation des nerfs caverneux, anastomose vésico-urétrale). Les résultats de la néphrectomie partielle sont également en faveur de l’assistance robotique si l’on prend en compte les paramètres périopératoires, les résultats fonctionnels et carcinologiques.
- 1 May 2016
- Published by Walter de Gruyter GmbH in Oncologie
- Vol. 18 (5) , 298-304
Chirurgie robot-assistée en uro-oncologie
Résumé La prostatectomie totale et la néphrectomie partielle robot-assistées sont les interventions les plus pratiquées en onco-urologie. En dix ans, la robotique s’est imposée pour la prostatectomie dans les centres équipés, du fait de l’amélioration technique apportée à la réalisation de cette intervention. Les résultats carcinologiques et fonctionnels sont comparables ou supérieurs à ceux de la prostatectomie laparoscopique ou par voie ouverte. L’assistance robotique est particulièrement utile en cas de patient obèse et de nécessité de dissection précise (conservation des nerfs caverneux, anastomose vésico-urétrale). Les résultats de la néphrectomie partielle sont également en faveur de l’assistance robotique si l’on prend en compte les paramètres périopératoires, les résultats fonctionnels et carcinologiques.
- 1 March 2016
- Published by Elsevier in European Urology Supplements
- Vol. 15 (3) , e618-e618a
618 Impact of targeted prostate biopsy using magnetic resonance imaging – ultrasound elastic fusion in men with suspicion of prostate cancer
- 1 March 2016
- Published by Elsevier in European Urology Supplements
- Vol. 15 (3) , e618-e618a
618 Impact of targeted prostate biopsy using magnetic resonance imaging – ultrasound elastic fusion in men with suspicion of prostate cancer